Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-12-10 / Pathol Oncol Res 2021;27:1610048https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-12-10 / Pathol Oncol Res 2021;27:16100482021-12-10 00:00:002021-12-10 00:00:00Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-12-03 / Clin Cancer Res 2021 Dec;https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-12-03 / Clin Cancer Res 2021 Dec;2021-12-03 00:00:002021-12-03 00:00:00A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-982https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-9822021-11-24 00:00:002023-03-22 14:41:40Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-1071https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-10712021-11-24 00:00:002021-11-24 00:00:00Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-11-11 / Prostate 2021 Nov;https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-11-11 / Prostate 2021 Nov;2021-11-11 00:00:002021-11-11 00:00:00Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-11-03 / Diseases 2021 Nov;9(4)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-11-03 / Diseases 2021 Nov;9(4)2021-11-03 00:00:002023-01-31 15:56:49Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-11-02 / Front Immunol 2021;12:770390https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-11-02 / Front Immunol 2021;12:7703902021-11-02 00:00:002021-11-02 00:00:00Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-10-25 / Phytother Res 2021 Oct;https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-10-25 / Phytother Res 2021 Oct;2021-10-25 00:00:002021-10-25 00:00:00Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-10-16 / Eur J Cancer 2021 Oct;158:123-132https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-10-16 / Eur J Cancer 2021 Oct;158:123-1322021-10-16 00:00:002021-10-16 00:00:00Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-10-09 / Life Sci 2021 Dec;286:120043https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-10-09 / Life Sci 2021 Dec;286:1200432021-10-09 00:00:002023-01-31 16:07:46Curcuma as an adjuvant in colorectal cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-10-05 / Front Immunol 2021;12:721830https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-10-05 / Front Immunol 2021;12:7218302021-10-05 00:00:002022-01-10 09:06:12Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002021-09-23 / Front Oncol 2021;11:730824https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2021-09-23 / Front Oncol 2021;11:7308242021-09-23 00:00:002021-09-23 00:00:00Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
Evaluation of response in patients with hepatocellular carcinoma treated with intratumoral dendritic cell vaccination using intravoxel incoherent motion (IVIM) MRI and histogram analysis
Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study
Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
The Efficacy of Dendritic Cell Vaccine for Newly Diagnosed Glioblastoma: A Meta-analysis of Randomized Controlled Studies
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
Curcuma as an adjuvant in colorectal cancer treatment
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer